Advertisements


Iovance Biotherapeutics provides clinical update on C-144-01, C-145-04

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Bellerophon Provides Business Update and Reports Third Quarter 2018 Financial Results

WARREN, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company, today provided a business update and reported financial results for the thi.....»»

Category: earningsSource: benzingaNov 7th, 2018

Mid-Day Market Update: EXFO Falls After Q4 Results; Iovance Biotherapeutics Shares Climb

Midway through trading Friday, the Dow traded up 0.80 percent to 25,252.55 while the NASDAQ climbed 1.82 percent to 7,462.44. The S&P also rose, gaining 1.14 percent to 2,759.37. read more.....»»

Category: blogSource: benzingaOct 12th, 2018

Iovance Biotherapeutics announces clinical trial updates with collaborators

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results

WARREN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics,┬áInc. (NASDAQ:BLPH) ("Bellerophon" or the "Company"), a clinical-stage biotherapeutics company, today prov.....»»

Category: earningsSource: benzingaMay 10th, 2018

SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2018 Financial Results

Conference call today at 8:00 a.m. ET NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a clinical-st.....»»

Category: earningsSource: benzingaNov 15th, 2018

Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Off.....»»

Category: earningsSource: benzingaNov 14th, 2018

Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update

GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three and nine months ended September 30, 2018......»»

Category: earningsSource: benzingaNov 13th, 2018

Atossa Genetics Announces Third Quarter 2018 Financial Results And Provides Company Update

SEATTLE, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and deli.....»»

Category: earningsSource: benzingaNov 13th, 2018

KalVista provides clinical update on KVD900

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

Asterias Biotherapeutics Reports Third Quarter Results

Clinical Programs Continue to ProgressRecent Transactions with affiliate of Novo Nordisk Increased Cash-on-Hand and Reduced Annual Operating ExpensesRecently Announced Definitive Merger Agreement with BioTime Creates Leading Cel.....»»

Category: earningsSource: benzingaNov 9th, 2018

Protalix BioTherapeutics Reports 2018 Third Quarter Results and Provides Corporate Update

CARMIEL, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE:PLX, TAS.....»»

Category: earningsSource: benzingaNov 7th, 2018

Iovance Biotherapeutics, Inc. (IOVA) CEO Maria Fardis on Q3 2018 Results - Earnings Call Transcript

Iovance Biotherapeutics, Inc. (IOVA) CEO Maria Fardis on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 6th, 2018

Aeglea BioTherapeutics presents clinical data on pegzilarginase at ESMO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 22nd, 2018

Loxo announces larotrectinib clinical update in patients with TRK fusion cancers

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 21st, 2018

Orgenesis subsidiary announces services agreement with Iovance Biotherapeutics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 18th, 2018

Iovance Biotherapeutics, MaSTherCell announce new MSA in Europe

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 18th, 2018

Iovance Biotherapeutics price target raised to $26 from $22 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 12th, 2018

Iovance Biotherapeutics 22M share spot secondary priced at $9.97

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 12th, 2018

Iovance Biotherapeutics price target raised to $25 from $22 at Oppenheimer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 12th, 2018

Iovance Biotherapeutics intends to sell shares in public offering

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018